Bridge Creek Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.69M | Sell |
27,281
-2,852
| -9% | -$283K | 0.75% | 57 |
|
|
2025
Q2 | $2.75M | Buy |
30,133
+3,297
| +12% | +$319K | 0.81% | 56 |
|
|
2025
Q1 | $3.04M | Buy |
26,836
+215
| +0.8% | +$23K | 0.96% | 49 |
|
|
2024
Q4 | $2.81M | Buy |
26,621
+460
| +2% | +$49.4K | 0.86% | 51 |
|
|
2024
Q3 | $2.82M | Sell |
26,161
-80
| -0.3% | -$8.73K | 0.85% | 53 |
|
|
2024
Q2 | $2.85M | Buy |
26,241
+941
| +4% | +$111K | 0.92% | 51 |
|
|
2024
Q1 | $3.34M | Buy |
25,300
+405
| +2% | +$50.6K | 1.07% | 44 |
|
|
2023
Q4 | $3.03M | Buy |
24,895
+107
| +0.4% | +$11.9K | 1.05% | 45 |
|
|
2023
Q3 | $2.78M | Hold |
24,788
| – | – | 1.05% | 43 |
|
|
2023
Q2 | $3.61M | Sell |
24,788
-180
| -0.7% | -$24.5K | 1.29% | 30 |
|
|
2023
Q1 | $3.23M | Buy |
24,968
+115
| +0.5% | +$14.4K | 1.21% | 40 |
|
|
2022
Q4 | $3.17M | Buy |
24,853
+147
| +0.6% | +$17.1K | 1.24% | 36 |
|
|
2022
Q3 | $2.58M | Buy |
24,706
+167
| +0.7% | +$18.3K | 1.11% | 42 |
|
|
2022
Q2 | $2.58M | Sell |
24,539
-880
| -3% | -$104K | 1.05% | 45 |
|
|
2022
Q1 | $3.25M | Buy |
25,419
+762
| +3% | +$91.8K | 1.08% | 44 |
|
|
2021
Q4 | $3.04M | Buy |
24,657
+185
| +0.8% | +$24.2K | 1.03% | 45 |
|
|
2021
Q3 | $3.48M | Buy |
24,472
+500
| +2% | +$73.6K | 1.27% | 37 |
|
|
2021
Q2 | $3.74M | Sell |
23,972
-134
| -0.6% | -$21.7K | 1.39% | 33 |
|
|
2021
Q1 | $3.75M | Sell |
24,106
-144
| -0.6% | -$22.3K | 1.42% | 35 |
|
|
2020
Q4 | $3.63M | Buy |
24,250
+77
| +0.3% | +$10.9K | 1.51% | 33 |
|
|
2020
Q3 | $3.19M | Sell |
24,173
-57
| -0.2% | -$7.45K | 1.5% | 32 |
|
|
2020
Q2 | $2.81M | Buy |
24,230
+863
| +4% | +$99.4K | 1.39% | 37 |
|
|
2020
Q1 | $2.29M | Sell |
23,367
-54
| -0.2% | -$7.08K | 1.35% | 36 |
|
|
2019
Q4 | $3.4M | Sell |
23,421
-77
| -0.3% | -$10.6K | 1.53% | 32 |
|
|
2019
Q3 | $3.13M | Sell |
23,498
-572
| -2% | -$73.9K | 1.52% | 30 |
|
|
2019
Q2 | $2.75M | Sell |
24,070
-541
| -2% | -$63.4K | 1.34% | 38 |
|
|
2019
Q1 | $3.05M | Buy |
24,611
+119
| +0.5% | +$13.5K | 1.56% | 34 |
|
|
2018
Q4 | $2.47M | Buy |
24,492
+226
| +0.9% | +$25.4K | 1.41% | 40 |
|
|
2018
Q3 | $3.1M | Buy |
24,266
+541
| +2% | +$64.3K | 1.55% | 34 |
|
|
2018
Q2 | $2.57M | Sell |
23,725
-726
| -3% | -$79K | 1.37% | 40 |
|
|
2018
Q1 | $2.59M | Buy |
24,451
+58
| +0.2% | +$6.74K | 1.39% | 41 |
|
|
2017
Q4 | $2.86M | Buy |
24,393
+46
| +0.2% | +$5.2K | 1.43% | 38 |
|
|
2017
Q3 | $2.77M | Buy |
24,347
+1,452
| +6% | +$168K | 1.45% | 38 |
|
|
2017
Q2 | $2.85M | Buy |
22,895
+2,426
| +12% | +$288K | 1.55% | 35 |
|
|
2017
Q1 | $2.43M | Buy |
20,469
+422
| +2% | +$47.8K | 1.35% | 40 |
|
|
2016
Q4 | $2.01M | Buy |
20,047
+14,801
| +282% | +$1.59M | 1.13% | 47 |
|
|
2016
Q3 | $662K | Buy |
5,246
+778
| +17% | +$96.1K | 0.38% | 60 |
|
|
2016
Q2 | $522K | Sell |
4,468
-43
| -1% | -$4.87K | 0.31% | 61 |
|
|
2016
Q1 | $467K | Sell |
4,511
-91
| -2% | -$8.8K | 0.27% | 63 |
|
|
2015
Q4 | $458K | Buy |
+4,602
| New | +$450K | 0.28% | 64 |
|
Other funds holding ZBH
Bridge Creek Capital Management's ZBH Position: Q3 2025 in Review
Bridge Creek Capital Management reduced its Zimmer Biomet (ZBH) stake by 9.5% in Q3 2025, selling an estimated $283K and leaving 27,281 shares worth $2.69M. The position accounts for 0.75% of the portfolio, ranked #57.
Bridge Creek Capital Management first reported a position in ZBH in Q4 2015 and has held it in 40 quarters since. The position peaked at $3.75M in Q1 2021. 966 funds tracked by Wall St. Rank hold ZBH as of Q3 2025.
- Bridge Creek Capital Management held 27,281 shares of Zimmer Biomet worth $2.69M as of Q3 2025.
- Bridge Creek Capital Management sold 2,852 Zimmer Biomet shares in Q3 2025, an estimated $283K.
- Zimmer Biomet made up 0.75% of Bridge Creek Capital Management's portfolio in Q3 2025, its #57 holding.
- Bridge Creek Capital Management first reported a position in Zimmer Biomet in Q4 2015 and has held it in 40 quarters since.
- Bridge Creek Capital Management's Zimmer Biomet position peaked at $3.75M in Q1 2021.
- 966 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2025.
Based on Bridge Creek Capital Management's 13F filing for Q3 2025, filed 14 Oct 2025.